PRAME Antikörper (AA 416-502)

Produktnummer ABIN7437779

Produktdetails anti-PRAME Antikörper

Target: PRAME (Preferentially Expressed Antigen in Melanoma (PRAME))

Bindungsspezifität: AA 416-502

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PRAME Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC)

Verwendungszweck: Polyclonal Antibody to Preferentially Expressed Antigen In Melanoma (PRAME)

Spezifität: The antibody is a rabbit polyclonal antibody raised against PRAME. It has been selected for its ability to recognize PRAME in immunohistochemical staining and western blotting.

Kreuzreaktivität: Schwein

Aufreinigung: Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Immunogen: Recombinant Preferentially Expressed Antigen In Melanoma (PRAME) corresdonding to Asn416~Leu502 (Accession # P78395)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

Western blotting: 0.01-2 μg/mL Immunohistochemistry: 5-20 μg/mL Immunocytochemistry: 5-20 μg/mL Optimal working dilutions must be determined by end user.

Kommentare:

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5 mg/mL

Buffer: Supplied as solution form in PBS, pH7.4, containing 0.02% NaN3, 50% glycerol

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Avoid repeated freeze/thaw cycles. Store at 4ºC for frequent use. Aliquot and store at -20ºC for 24 months.

Haltbarkeit: 24 months

Details zu PRAME

Target: PRAME (Preferentially Expressed Antigen in Melanoma (PRAME))

Andere Bezeichnung: Preferentially Expressed Antigen In Melanoma (PRAME Produkte)

Hintergrund: MAPE, OIP4, CT130, Cancer/Testis Antigen 130, Opa-interacting protein 4, Melanoma antigen preferentially expressed in tumors

Pathways: Retinoic Acid Receptor Signaling Pathway, Nuclear Hormone Receptor Binding